Virax Biolabs Group Stock Price History

VRAX Stock  USD 1.27  0.04  3.25%   
If you're considering investing in Virax Stock, it is important to understand the factors that can impact its price. As of today, the current price of Virax Biolabs stands at 1.27, as last reported on the 21st of March, with the highest price reaching 1.27 and the lowest price hitting 1.23 during the day. Virax Biolabs Group owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0559, which indicates the firm had a -0.0559 % return per unit of risk over the last 3 months. Virax Biolabs Group exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Virax Biolabs' Coefficient Of Variation of (9,911), variance of 86.43, and Risk Adjusted Performance of 1.0E-4 to confirm the risk estimate we provide.
  
At this time, Virax Biolabs' Total Stockholder Equity is fairly stable compared to the past year. Capital Stock is likely to rise to 3,108 in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 1.4 M in 2025. . At this time, Virax Biolabs' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 0.26 in 2025, whereas Price To Sales Ratio is likely to drop 10.30 in 2025. Virax Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0559

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVRAX

Estimated Market Risk

 7.61
  actual daily
67
67% of assets are less volatile

Expected Return

 -0.43
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.06
  actual daily
0
Most of other assets perform better
Based on monthly moving average Virax Biolabs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Virax Biolabs by adding Virax Biolabs to a well-diversified portfolio.
Price Book
0.6329
Enterprise Value Ebitda
0.4228
Price Sales
62.9255
Shares Float
3.8 M
Wall Street Target Price
20

Virax Biolabs Stock Price History Chart

There are several ways to analyze Virax Stock price data. The simplest method is using a basic Virax candlestick price chart, which shows Virax Biolabs price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 6, 20253.11
Lowest PriceMarch 19, 20251.23

Virax Biolabs March 21, 2025 Stock Price Synopsis

Various analyses of Virax Biolabs' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Virax Stock. It can be used to describe the percentage change in the price of Virax Biolabs from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Virax Stock.
Virax Biolabs Price Rate Of Daily Change 1.03 
Virax Biolabs Price Action Indicator 0.04 
Virax Biolabs Price Daily Balance Of Power 1.00 

Virax Biolabs March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Virax Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Virax Biolabs intraday prices and daily technical indicators to check the level of noise trading in Virax Stock and then apply it to test your longer-term investment strategies against Virax.

Virax Stock Price History Data

The price series of Virax Biolabs for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 1.88 with a coefficient of variation of 19.9. The daily prices for the period are distributed with arithmetic mean of 1.85. The median price for the last 90 days is 1.75. The company experienced 1:10 stock split on 18th of December 2023.
OpenHighLowCloseVolume
03/21/2025
 1.23  1.27  1.23  1.27 
03/20/2025 1.23  1.27  1.21  1.27  21,967 
03/19/2025 1.26  1.27  1.22  1.23  85,573 
03/18/2025 1.28  1.34  1.25  1.26  98,160 
03/17/2025 1.38  1.43  1.25  1.28  275,815 
03/14/2025 1.30  1.42  1.30  1.37  103,313 
03/13/2025 1.47  1.58  1.26  1.29  327,468 
03/12/2025 1.47  1.51  1.47  1.47  102,138 
03/11/2025 1.41  1.52  1.41  1.48  259,113 
03/10/2025 1.45  1.52  1.35  1.37  228,844 
03/07/2025 1.36  1.45  1.32  1.40  92,835 
03/06/2025 1.29  1.40  1.22  1.36  164,917 
03/05/2025 1.47  1.50  1.33  1.36  216,634 
03/04/2025 1.58  1.63  1.44  1.47  140,521 
03/03/2025 1.68  1.84  1.59  1.59  209,316 
02/28/2025 1.73  1.75  1.65  1.67  51,687 
02/27/2025 1.72  1.85  1.68  1.71  203,751 
02/26/2025 1.70  1.82  1.65  1.73  212,837 
02/25/2025 1.73  1.75  1.62  1.69  107,996 
02/24/2025 1.95  1.95  1.60  1.73  367,314 
02/21/2025 1.78  1.91  1.70  1.87  675,265 
02/20/2025 1.75  1.82  1.65  1.82  92,125 
02/19/2025 1.85  1.86  1.75  1.75  87,197 
02/18/2025 1.93  1.94  1.81  1.88  190,622 
02/14/2025 1.89  1.97  1.86  1.90  51,199 
02/13/2025 2.07  2.09  1.84  1.88  153,543 
02/12/2025 1.90  2.10  1.81  2.04  367,278 
02/11/2025 1.83  1.92  1.76  1.89  753,457 
02/10/2025 1.63  1.83  1.60  1.62  419,009 
02/07/2025 1.79  2.29  1.58  1.71  1,629,219 
02/06/2025 1.75  1.83  1.69  1.80  113,880 
02/05/2025 1.67  1.86  1.67  1.75  370,574 
02/04/2025 1.67  1.70  1.61  1.67  37,479 
02/03/2025 1.66  1.85  1.56  1.67  129,145 
01/31/2025 1.72  1.75  1.60  1.69  119,119 
01/30/2025 1.92  2.01  1.55  1.69  363,729 
01/29/2025 2.04  2.09  1.87  1.92  130,143 
01/28/2025 2.15  2.15  1.99  2.05  54,364 
01/27/2025 2.10  2.20  2.05  2.07  172,877 
01/24/2025 2.16  2.16  1.99  2.13  170,392 
01/23/2025 2.08  2.20  2.06  2.07  126,777 
01/22/2025 2.10  2.33  2.10  2.14  97,779 
01/21/2025 2.21  2.22  2.03  2.09  123,068 
01/17/2025 2.30  2.33  2.11  2.18  266,655 
01/16/2025 2.06  2.17  1.85  2.14  268,765 
01/15/2025 2.20  2.46  2.00  2.07  292,834 
01/14/2025 2.45  2.52  2.19  2.29  191,084 
01/13/2025 2.42  2.61  2.30  2.38  351,501 
01/10/2025 2.38  2.47  2.21  2.42  125,257 
01/08/2025 2.73  2.73  2.14  2.34  352,380 
01/07/2025 3.00  3.10  2.53  2.77  860,609 
01/06/2025 2.57  3.20  2.33  3.11  2,175,045 
01/03/2025 2.26  2.73  2.26  2.43  972,782 
01/02/2025 2.26  2.26  2.07  2.21  302,424 
12/31/2024 1.96  2.42  1.95  2.25  643,040 
12/30/2024 2.29  2.31  1.83  2.06  642,697 
12/27/2024 1.67  2.18  1.67  2.10  946,423 
12/26/2024 1.80  1.81  1.64  1.73  204,843 
12/24/2024 1.82  1.87  1.62  1.72  182,795 
12/23/2024 1.70  2.05  1.68  1.92  404,628 
12/20/2024 1.79  1.93  1.70  1.75  382,140 

About Virax Biolabs Stock history

Virax Biolabs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Virax is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Virax Biolabs Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Virax Biolabs stock prices may prove useful in developing a viable investing in Virax Biolabs
Last ReportedProjected for Next Year
Common Stock Shares Outstanding2.3 M1.4 M
Net Loss-4.9 M-4.7 M

Virax Biolabs Stock Technical Analysis

Virax Biolabs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Virax Biolabs technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Virax Biolabs trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Virax Biolabs Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Virax Biolabs' price direction in advance. Along with the technical and fundamental analysis of Virax Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Virax to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Virax Stock Analysis

When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.